The Coil Assisted Flow Diverters Market is being driven in part by the rising prevalence of brain aneurysms, risk factors associated with them, and a growing preference for minimally invasive treatments. Growing public awareness of viable therapies and government initiatives to lower the incidence of intracranial aneurysms are a few of other factors affecting the market’s rise.
Coil-assisted flow diverters have gained increased traction in 2021 as a result of various devices that have received FDA approval for use in the treatment of brain aneurysms. The recent approval of coil-assisted flow diverters is expected to completely devastate the market for embolic coils, which were once thought of as the gold standard for treating cerebral aneurysms.
Experience Exponential Growth: Secure Your Sample Report and Dominate the Coil Assisted Flow Diverters Market @ https://www.futuremarketinsights.com/reports/sample/rep-gb-12565
In 2022, the market for coil-assisted flow diverters is anticipated to be worth US$283.2 million. With a fast increasing CAGR of 7.7% between 2023 and 2033, this market is projected to earn revenues of US$ 305.01 million and US$ 640.42 million, respectively. To embolise cerebral aneurysms, coil-assisted flow diverters, which resemble stents, are used. Therefore, the growing incidence of cerebral aneurysms is driving the market for coil-assisted flow diverters. The 2017 Survey conducted by the Ministry of Health, Labour, and Welfare estimates that 1.1 million people in Japan suffer from cerebrovascular diseases like subarachnoid haemorrhages and cerebral aneurysms.
Additionally, 1 in 12,600 people in England encounter a rupture brain aneurysm each year, according to the National Health Service (NHS). According to research titled “Unruptured Intracranial Aneurysms—Pathogenesis and Personalised Treatment” that was published in Deutsches rzteblatt International in 2020 (IA), around 2 million people in Germany have suffered an unruptured intracranial aneurysm. Because brain aneurysms are becoming more common, there is a substantial market for coil-assisted flow diverters.
Key Takeaways from the Coil Assisted Flow Diverters (CAFD) market are as follows:
- Growing demand: The market for Coil Assisted Flow Diverters has been experiencing significant growth due to increasing cases of intracranial aneurysms and the need for effective treatment options. CAFD devices are being increasingly adopted as a minimally invasive treatment option, driving market demand.
- Superior outcomes: Coil Assisted Flow Diverters offer several advantages over traditional treatment methods for intracranial aneurysms. They provide better aneurysm occlusion rates, reduce the risk of recurrence, and have a lower risk of complications compared to other treatment options. These factors contribute to their rising popularity in the market.
In case of any queries, don’t hesitate to contact our analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-12565
- Technological advancements: The market is witnessing continuous technological advancements in Coil Assisted Flow Diverters, leading to improved device designs and enhanced treatment outcomes. Manufacturers are focusing on developing devices with better navigability, increased flexibility, and improved flow diversion capabilities.
- Rising prevalence of intracranial aneurysms: The increasing prevalence of intracranial aneurysms globally is a significant driver for the Coil Assisted Flow Diverters market. Factors such as aging population, lifestyle changes, and improved diagnostic techniques contribute to the higher detection rate of aneurysms, thereby increasing the demand for effective treatment options like CAFD.
- Favorable reimbursement policies: Governments and healthcare organizations in several countries have recognized the clinical benefits of Coil Assisted Flow Diverters and have implemented favorable reimbursement policies. This has led to increased accessibility and affordability of CAFD devices, further boosting market growth.
Coil Assisted Flow Diverters Market: Drivers and Restraints:
Drivers:
- Growing prevalence of intracranial aneurysms: The incidence of intracranial aneurysms has been increasing globally, primarily due to factors such as aging populations, lifestyle changes, and improved diagnostic capabilities. This rising prevalence creates a significant demand for effective treatment options like CAFDs.
- Minimally invasive nature: Coil Assisted Flow Diverters offer a less invasive alternative to traditional surgical treatments for intracranial aneurysms. They can be placed using endovascular techniques, reducing the need for open surgery and associated risks, such as infection and longer recovery times. This minimally invasive nature attracts both patients and healthcare providers.
Unleash Your Potential: Customize Your Report to Master the Coil Assisted Flow Diverters Market Landscape @ https://www.futuremarketinsights.com/customization-available/rep-gb-12565
Restraints:
- High cost: The cost of CAFDs can be relatively high, including the cost of the device itself and the associated procedure. This can limit their adoption, especially in regions with limited healthcare budgets or where reimbursement policies may not adequately cover the expenses.
- Lack of awareness and expertise: CAFDs are relatively new in the market, and their adoption may be hindered by a lack of awareness and expertise among healthcare professionals. Training and education are crucial to ensure proper utilization of CAFDs and to increase their acceptance.
Coil Assisted Flow Diverters Market: Key Players
The key players of global coil assisted flow diverters market include
- Medtronic
- DePuy Synthes
- Stryker
- MicroPort
- OBEX Medical
- Abbott
- Cardiatis
- ADMEDES
- Penumbra Inc. and Balt.
Coil Assisted Flow Diverters Market: Segmentation
The global coil assisted flow diverters market is segmented into the types of applications, distribution channels and regions.
Applications:
- Wide-neck bifurcation aneurysms
- Bifurcation aneurysms
Seize this Opportunity for Detailed Market Intel: Purchase Now to Access @ https://www.futuremarketinsights.com/checkout/12565
Distribution Channels:
- Hospitals
- Clinics
- Ambulatory Surgical Centres
Regional analysis includes
- North America (USA. Canada)
- Latin America (Mexico. Brazil)
- Western Europe (Germany Italy France, United Kingdom, Spain)
- Eastern Europe (Poland Russia)
- Asia-Pacific excluding Japan (China India ASEAN Australia & New Zealand)
- Japan
- Middle East and Africa (GCC Countries South Africa Northern Africa)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube